Literature DB >> 1572247

[Estimation of the incidence of diabetes in the Federal Republic of Germany based on insurance data. A secondary data analysis of a representative random sample of locally insured persons in the city of Dortmund].

H Hauner1, L von Ferber, I Köster.   

Abstract

All records relating to medical prescriptions and services relating to diabetes for a representative sample (n = 6478) of inhabitants of Dortmund in 1988, who were members of the Local Health Insurance in Dortmund, were analysed. 264 patients (4.08%) were receiving antidiabetic drugs during that year, 198 (3.06%) oral ones, 42 (0.65%) insulin and 24 (0.37%) both. 12.41% of all those insured over the age of 60 were on antidiabetic drugs, more women than men (5.08 vs 2.94%; P less than 0.001). The most frequently used oral antidiabetics were sulphonylurea ones (95.1%), while the proportion of biguanides was only 4.4%. On the basis of established diagnosis, regular blood sugar and HbA1 tests, as well as optic fundi examination, a further 104 persons (1.60%) are assumed to have diabetes but not treated by drugs. This sample indicates an overall prevalence of diabetes of 5.68% among the population. Relating it to the age and sex pattern of the population of the Federal Republic of Germany this corresponds to a prevalence of diagnosed diabetes of 4.82%. Thus there are probably a little less than 4 million diabetic citizens of the Federal Republic of Germany.

Entities:  

Mesh:

Year:  1992        PMID: 1572247     DOI: 10.1055/s-2008-1062359

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  Quality of centralized diabetes care: a population-based study in the German Democratic Republic 1989-1990.

Authors:  U A Müller; I S Ross; H Klinger; S Geisenheiner; E A Chantelau
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

2.  Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insurance.

Authors:  Michael W J Boehme; Gisela Buechele; Julia Frankenhauser-Mannuss; Jana Mueller; Dietlinde Lump; Bernhard O Boehm; Dietrich Rothenbacher
Journal:  BMC Public Health       Date:  2015-09-03       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.